A Pipeline For Malignancy And Therapy Agnostic Assessment Of Cancer Drug Response Using Cell Mass Measurements

Kimmerling, R.J., Stevens, M.M., Olcum, S., Minnah, A., Vacha, M., LaBella, R., Ferri , M., Wasserman, S.C., Fujii, J., Shaheen, Z., Sundaresan, S., Ribadeneyra, D., Jayabalan, D.S., Agte4, S., Aleman, A., Criscitiello, J.A., Niesvizky, R., Luskin , M.R., Parekh, S., Rosenbaum, C.A., Tamrazi, A., & Reid, C.A. A Pipeline For Malignancy And Therapy Agnostic Assessment Of Cancer Drug Response Using Cell Mass Measurements. Communications Biology. 2022, 5:1295. Nov-22.

Date

BioLife Solutions logo

This website uses cookies to ensure you get the best experience on our website.